跳至主要内容
临床试验/NCT00965926
NCT00965926已完成1 期

A Pharmacokinetic Study in Healthy Non-elderly Male and Female Volunteers to Investigate the Effect of Food on the Pharmacokinetics of YM178

Astellas Pharma Inc0 个研究点目标入组 72 人开始时间: 2009年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
72
主要终点
Plasma concentration of unchanged YM178

研究概览

简要总结

The purpose of the study is to evaluate the effect of food intake on the pharmacokinetics of YM178 in healthy, non-elderly adult subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
None

入排标准

年龄范围
20 Years 至 54 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy as judged by the investigator/subinvestigator based on the results of physical examinations and all lab tests
  • Body weight (at screening); female ≥40.0 kg, <70.0 kg, male ≥50.0 kg, <80.0 kg
  • BMI (at screening): ≥17.6, <26.4
  • Written informed consent has been obtained

排除标准

  • Received any investigational drugs within 120 days before the screening test
  • Donated 400 mL of whole blood within 90 days, 200 mL of whole blood within 30 days, or blood components within 14 days before the screening test
  • Received medication within 7 days before hospital admission or is scheduled to receive medication
  • Females who are lactating, pregnant, potentially child-bearing, or willing to get pregnant during the study period
  • History of drug allergies
  • Upper gastrointestinal disease (e.g. nausea, vomiting, stomachache) within 7 days before hospital admission

研究组 & 干预措施

Low dose group

Experimental

3 way cross-over. Fasting, normal diet and high-fat diet

干预措施: YM178 (Drug)

High dose group

Experimental

3 way cross-over. Fasting, normal diet and high-fat diet

干预措施: YM178 (Drug)

结局指标

主要结局

Plasma concentration of unchanged YM178

时间窗: Up to 96 hours post dose

次要结局

  • Urinary concentration of unchanged YM178(Up to 96 hours post dose)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验